Screener
Recursion Pharmaceuticals, Inc. RXRX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Notes payable and financing lease liabilities, non-current | 4,753 | 9,564 |
| Deferred tax liabilities | 18,313 | 23,255 |
| Other liabilities, non-current | 2,702 | 2,080 |
| Total liabilities | 297,665 | 343,265 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity | ||
| Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of June 30, 2026 and December 31, 2025; 534,120,235 shares (Class A 533,191,318, Class B — and Exchangeable 928,917) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 5 | 5 |
| Additional paid-in capital | 3,211,515 | 3,170,145 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s total liabilities?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total liabilities of $297.67M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total liabilities decreased by 22.3% year-over-year, from $383.21M to $297.67M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s total liabilities has grown at a 43.4% compound annual growth rate (CAGR), from $56.56M to $343.27M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Recursion Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude